ST6GAL1 Is a Novel Serum Biomarker for Lenvatinib-Susceptible FGF19-Driven Hepatocellular Carcinoma

伦瓦提尼 肝细胞癌 FGF19型 内科学 医学 肿瘤科 肝细胞癌 生物标志物 癌症研究 生物 成纤维细胞生长因子 索拉非尼 受体 遗传学
作者
Yuta Myojin,Takahiro Kodama,Kazuki Maesaka,Daisuke Motooka,Yu Sato,Satoshi Tanaka,Yuichi Abe,Kazuyoshi Ohkawa,Eiji Mita,Yoshito Hayashi,Hayato Hikita,Ryotaro Sakamori,Tomohide Tatsumi,Ayumu Taguchi,Hidetoshi Eguchi,Tetsuo Takehara
出处
期刊:Clinical Cancer Research [American Association for Cancer Research]
卷期号:27 (4): 1150-1161 被引量:59
标识
DOI:10.1158/1078-0432.ccr-20-3382
摘要

Abstract Purpose: Hepatocellular carcinoma (HCC) is characterized by high intertumor heterogeneity of genetic drivers. Two multitarget tyrosine kinase inhibitors (TKI), lenvatinib and sorafenib, are used as standard-of-care chemotherapeutics in patients with advanced HCC, but a stratification strategy has not been established because of a lack of efficacious biomarkers. Therefore, we sought biomarkers that indicate lenvatinib-susceptible HCC. Experimental Design: We performed genetic screening of HCC driver genes involved in TKI susceptibility using a novel HCC mouse model in which tumor diversity of genetic drivers was recapitulated. A biomarker candidate was evaluated in human HCC cell lines. Secreted proteins from HCC cells were then screened using mass spectrometry. Serum and tumor levels of the biomarker candidates were analyzed for their association and prediction of overall survival in patients with HCC. Results: We found that lenvatinib selectively eliminated FGF19-expressing tumors, whereas sorafenib eliminated MET- and NRAS-expressing tumors. FGF19 levels and lenvatinib susceptibility were correlated in HCC cell lines, and FGF19 inhibition eliminated lenvatinib susceptibility. Lenvatinib-resistant HCC cell lines, generated by long-term exposure to lenvatinib, showed FGF19 downregulation but were resensitized to lenvatinib by FGF19 reexpression. Thus, FGF19 is a tumor biomarker of lenvatinib-susceptible HCC. Proteome and secretome analyses identified ST6GAL1 as a tumor-derived secreted protein positively regulated by FGF19 in HCC cells. Serum ST6GAL1 levels were positively correlated with tumor FGF19 expression in patients with surgically resected HCC. Among patients with serum ST6GAL1-high HCC who underwent TKI therapy, lenvatinib therapy showed significantly better survival than sorafenib. Conclusions: Serum ST6GAL may be a novel biomarker that identifies lenvatinib-susceptible FGF19-driven HCC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Laurel完成签到,获得积分10
刚刚
自然剑发布了新的文献求助10
3秒前
CipherSage应助松鼠桂鱼采纳,获得10
3秒前
失眠的狗发布了新的文献求助10
4秒前
哈尔婧完成签到,获得积分10
4秒前
4秒前
5秒前
Arvilzzz完成签到,获得积分10
7秒前
7秒前
Abby完成签到,获得积分10
9秒前
拼搏的松鼠完成签到,获得积分10
9秒前
10秒前
SYLH应助廿澍采纳,获得30
10秒前
木水发布了新的文献求助10
10秒前
齐映雁完成签到 ,获得积分10
11秒前
遥远发布了新的文献求助30
11秒前
13秒前
14秒前
15秒前
15秒前
xn201120发布了新的文献求助10
15秒前
16秒前
zhangmeimei发布了新的文献求助10
17秒前
搜集达人应助自然剑采纳,获得10
18秒前
超级白猫发布了新的文献求助10
18秒前
19秒前
19秒前
19秒前
樊孟完成签到,获得积分10
20秒前
20秒前
坚定的啤酒完成签到,获得积分10
20秒前
21秒前
21秒前
Vivian完成签到,获得积分10
21秒前
22秒前
25秒前
猫猫头发布了新的文献求助30
26秒前
羊羊羊发布了新的文献求助10
27秒前
超级白猫完成签到,获得积分10
27秒前
xn201120发布了新的文献求助10
28秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976267
求助须知:如何正确求助?哪些是违规求助? 3520472
关于积分的说明 11203425
捐赠科研通 3257089
什么是DOI,文献DOI怎么找? 1798589
邀请新用户注册赠送积分活动 877785
科研通“疑难数据库(出版商)”最低求助积分说明 806523